| In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods S Di Giovanni, A Borloz, A Urbain, A Marston, K Hostettmann, PA Carrupt, ... European journal of pharmaceutical sciences 33 (2), 109-119, 2008 | 161 | 2008 |
| Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of α-synuclein and β-amyloid and protect against amyloid-induced toxicity S Di Giovanni, S Eleuteri, KE Paleologou, G Yin, M Zweckstetter, ... Journal of Biological Chemistry 285 (20), 14941-14954, 2010 | 157 | 2010 |
| International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis … R Giacomelli, A Afeltra, A Alunno, C Baldini, E Bartoloni-Bocci, ... Autoimmunity Reviews 16 (9), 911-924, 2017 | 142 | 2017 |
| The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species CA Braga, C Follmer, FL Palhano, E Khattar, MS Freitas, L Romão, ... Journal of molecular biology 405 (1), 254-273, 2011 | 107 | 2011 |
| Switch peptide via Staudinger reaction N Nepomniaschiy, V Grimminger, A Cohen, S DiGiovanni, HA Lashuel, ... Organic letters 10 (22), 5243-5246, 2008 | 60 | 2008 |
| Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease S Eleuteri, S Di Giovanni, E Rockenstein, M Mante, A Adame, M Trejo, ... Neurobiology of disease 74, 144-157, 2015 | 34 | 2015 |
| Identification of novel multifunctional compounds for the treatment of some aging related neurodegenerative diseases L Novaroli, A Daina, F Bertolini, S Di Giovanni, J Bravo, M Reist, ... Chimia 59 (6), 315-315, 2005 | 14 | 2005 |
| Blocking Aβ seeding-mediated aggregation and toxicity in an animal model of Alzheimer's Disease: A novel therapeutic strategy for neurodegeneration S Eleuteri, S Di Giovanni, E Rockenstein, M Mante, A Adame, M Trejo, ... Neurobiology of disease 74, 144, 2014 | 10 | 2014 |
| The pharmacist’s perspective to advance person-and people-centered care O Bugnon, S Di Giovanni, M Buchmann International Journal of Person Centered Medicine 2 (1), 129-134, 2012 | 5 | 2012 |
| Polypharmacy as predictor of drug cost, length of hospital stay and mortality rate in nursing homes: a retrospective analysis of pharmacy medication records S Di Giovanni, MJ Zeukeng, P Ballabeni, I Anguish, JF Locca, O Bugnon 41st ESCP symposium on clinical pharmacy: personalised and safe therapy 35, 2013 | 1 | 2013 |
| Multifunctional hits against Alzheimer's and Parkinson's diseases: screening for acetylcholinesterase and protein aggregation inhibitors S Di Giovanni Verlag nicht ermittelbar, 2008 | | 2008 |
